However, clinical data showed no significant difference in NRF1 transcriptional levels between normal and breast cancer tissues (Supplementary Fig. 4), supporting our notion that the regulation of NRF1 is mainly at the posttranslational level in patients. This evidence concerns the gene NRF1 and breast carcinoma.